Barbara E. Mahon, MD
Adjunct Assistant Professor
Boston University School of Public Health
Dept of Epidemiology

MD, University of California San Francisco
MPH, University of California, Berkeley

favorite icon LinkedIn

Dr. Mahon received her MD and clinical training in pediatrics from the University of California, San Francisco and her MPH from the University of California, Berkeley. She trained in CDC’s Epidemic Intelligence Service (EIS). Dr. Mahon is deputy chief of the Enteric Diseases Epidemiology and Surveillance Branch at the Centers for Disease Control and Prevention (CDC). The branch is responsible for national surveillance for enteric diseases. It conducts epidemiologic studies of the burden, trends, and food source attribution of foodborne diseases caused by Listeria , Salmonella, and E. coli O157, among other pathogens. The branch’s work also focuses on vulnerable populations, including older adults, young children, and other groups, with the goal of creating knowledge needed to protect people by preventing disease. Dr. Mahon has a broad background in infectious disease epidemiology, having worked on foodborne diseases, vaccine-preventable diseases, and sexually transmitted diseases in academic and industry positions as well as in government.

Adjunct Assistant Professor
Boston University School of Medicine
General Pediatrics

Genetic and Environmental Factors in PCV7 Vaccine Effect
09/30/2004 - 09/29/2008 (PI)
HHS/Center for Disease Control
5 K01 CI00301 03

Rubella and Varicella Immunity Among Adolescents Seeking Care in an Urban Emergency Department
01/01/2003 - 12/31/2003 (PI)


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Mahon BE, Simon J, Widdowson MA, Samai M, Rogier E, Legardy-Williams J, Liu K, Schiffer J, Lange J, DeByle C, Pinner R, Schuchat A, Slutsker L, Goldstein S. Baseline Asymptomatic Malaria Infection and Immunogenicity of rVSV?G-ZEBOV-GP Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE). J Infect Dis. 2021 May 20. PMID: 34013349
  2. Morgan OW, Aguilera X, Ammon A, Amuasi J, Fall IS, Frieden T, Heymann D, Ihekweazu C, Jeong EK, Leung GM, Mahon B, Nkengasong J, Qamar FN, Schuchat A, Wieler LH, Dowell SF. Disease surveillance for the COVID-19 era: time for bold changes. Lancet. 2021 06 19; 397(10292):2317-2319. PMID: 34000258; PMCID: PMC8121493; DOI: 10.1016/S0140-6736(21)01096-5;
  3. Jacobs Slifka KM, Blackstock A, Nguyen V, Schwensohn C, Gieraltowski L, Mahon BE. Estimating the Incubation Period of Salmonella Urinary Tract Infections Using Foodborne Outbreak Data. Foodborne Pathog Dis. 2020 10; 17(10):628-630. PMID: 32735492
  4. Hallowell BD, Carlson CM, Jacobs JR, Pomeroy M, Steinberg J, Tenforde MW, McDonald E, Foster L, Feldstein LR, Rolfes MA, Haynes A, Abedi GR, Odongo GS, Saruwatari K, Rider EC, Douville G, Bhakta N, Maniatis P, Lindstrom S, Thornburg NJ, Lu X, Whitaker BL, Kamili S, Sakthivel SK, Wang L, Malapati L, Murray JR, Lynch B, Cetron M, Brown C, Roohi S, Rotz L, Borntrager D, Ishii K, Moser K, Rasheed M, Freeman B, Lester S, Corbett KS, Abiona OM, Hutchinson GB, Graham BS, Pesik N, Mahon B, Braden C, Behravesh CB, Stewart R, Knight N, Hall AJ, Killerby ME. Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020. Emerg Infect Dis. 2020 Sep; 26(9):1998-2004. PMID: 32620182; PMCID: PMC7454104; DOI: 10.3201/eid2609.201590;
  5. Klugman KP, Zewdu S, Mahon BE, Dowell SF, Srikantiah P, Laserson KF, Tappero JW, Zaidi AK, Mundel T. Younger ages at risk of Covid-19 mortality in communities of color. Gates Open Res. 2020; 4:69. PMID: 32715283; PMCID: PMC7360879; DOI: 10.12688/gatesopenres.13151.1;
  6. Legardy-Williams JK, Carter RJ, Goldstein ST, Jarrett OD, Szefer E, Fombah AE, Tinker SC, Samai M, Mahon BE. Pregnancy Outcomes among Women Receiving rVSV?-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola. Emerg Infect Dis. 2020 03; 26(3):541-548. PMID: 32017677; PMCID: PMC7045819; DOI: 10.3201/eid2603.191018;
  7. Luvsansharav UO, Wakhungu J, Grass J, Oneko M, Nguyen V, Bigogo G, Ogola E, Audi A, Onyango D, Hamel MJ, Montgomery JM, Fields PI, Mahon BE. Exploration of risk factors for ceftriaxone resistance in invasive non-typhoidal Salmonella infections in western Kenya. PLoS One. 2020; 15(3):e0229581. PMID: 32126103; PMCID: PMC7053705; DOI: 10.1371/journal.pone.0229581;
  8. Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM, Brisson M, Mahon BE, Henao-Restrepo AM. An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool. Vaccine. 2019 07 18; 37(31):4376-4381. PMID: 31242963; PMCID: PMC6620503; DOI: 10.1016/j.vaccine.2019.06.019;
  9. Judd MC, Hoekstra RM, Mahon BE, Fields PI, Wong KK. Epidemiologic patterns of human Salmonella serotype diversity in the USA, 1996-2016. Epidemiol Infect. 2019 01; 147:e187. PMID: 31063111; PMCID: PMC6518743; DOI: 10.1017/S0950268819000724;
  10. Halpin AL, Gu W, Wise ME, Sejvar JJ, Hoekstra RM, Mahon BE. Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign. Epidemiol Infect. 2018 10; 146(13):1740-1745. PMID: 29986777; PMCID: PMC6123263; DOI: 10.1017/S0950268818001802;
Showing 10 of 112 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 112 publications over 29 distinct years, with a maximum of 14 publications in 2012


Contact for Mentoring:

715 Albany St Talbot Building
Boston MA 02118
Google Map

Mahon's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department